Search Results - "Carrascosa, J. M."

Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis by Dávila-Seijo, P., Dauden, E., Carretero, G., Ferrandiz, C., Vanaclocha, F., Gómez-García, F.-J., Herrera-Ceballos, E., De la Cueva-Dobao, P., Belinchón, I., Sánchez-Carazo, J.-L., Alsina, M., López-Estebaranz, J.-L., Ferrán, M., Torrado, R., Carrascosa, J.-M., Llamas, M., Rivera, R., Jiménez-Puya, R., García-Doval, I.

“…Background Few reported studies compare drug survival in moderate‐to‐severe psoriasis vulgaris. Objectives To describe and compare drug survival of systemic…”
Get full text

Clinical relevance of immunogenicity of biologics in psoriasis: Implications for treatment strategies by Carrascosa, J.-M., van Doorn, M.B.A., Lahfa, M., Nestle, F.O., Jullien, D., Prinz, J.C.

“…Biological drugs such as the tumour necrosis factor inhibitors have revolutionized the treatment of psoriasis, but some have the potential to induce an…”
Get full text

Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO) by Pinter, A., Costanzo, A., Khattri, S., Smith, S. D., Carrascosa, J. M., Tada, Y., Riedl, E., Reich, A., Brnabic, A., Haustrup, N., Lampropoulou, A., Lipkovich, I., Kadziola, Z., Paul, C., Schuster, C.

“…Introduction Given the chronic nature of psoriasis (PsO), more studies are needed that directly compare the effectiveness of different biologics over long…”
Get full text

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting by Navarro, R., Vilarrasa, E., Herranz, P., Puig, L., Bordas, X., Carrascosa, J.M., Taberner, R., Ferrán, M., García-Bustinduy, M., Romero-Maté, A., Pedragosa, R., García-Diez, A., Daudén, E.

“…Summary Background  Both the safety and efficacy of biologic therapy may be affected in the presence of highly prevalent chronic viral hepatitis. Objectives …”
Get full text

Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO) by Pinter, A., Costanzo, A., Khattri, S., Smith, S. D., Carrascosa, J. M., Tada, Y., Riedl, E., Reich, A., Brnabic, A., Haustrup, N., Lampropoulou, A., Lipkovich, I., Kadziola, Z., Paul, C., Schuster, C.

Get full text

Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis by Romaní, J., Caixàs, A., Carrascosa, J.M., Ribera, M., Rigla, M., Luelmo, J.

“…Summary Background  Previous studies have shown increased prevalence of metabolic syndrome in patients with psoriasis. Objectives  To characterize the…”
Get full text

Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry by Sánchez-Moya, A.I., García-Doval, I., Carretero, G., Sánchez-Carazo, J., Ferrandiz, C., Herrera Ceballos, E., Alsina, M., Ferrán, M., López-Estebaranz, J.-L., Gómez-García, F., De la Cueva Dobao, P., Carrascosa, J.-M., Vanaclocha, F., Belinchón, I., Peral, F., Dauden, E.

“…Introduction  The incidence of tuberculosis (TB) or the prevalence of latent tuberculosis infection (LTBI) in psoriasis patients has not been described in the…”
Get full text

Updated Review on Treatment of Atopic Dermatitis by Armario-Hita, J C, Galán-Gutiérrez, M, Dodero-Anillo, J M, Carrascosa, J M, Ruiz-Villaverde, R

“…Atopic dermatitis (AD) is a chronic or chronically recurrent Inflammatory dermatosis associated with multiple triggers that has a complex pathophysiological…”
Get full text

Phototoxic reaction to a combined oral contraceptive (levonorgestrel/ethinylestradiol) by Richarz, N A, Aguilera, J, Castillo, G, Fuente, M J, Ferrándiz, C, Carrascosa, J M

“…We present the case of a phototoxic skin reaction due to the regular intake of a combined oral contraceptive (levonorgestrel/ethinylestradiol). Upon…”
Get more information

Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab by Brunner, P.M., Conrad, C., Vender, R., Grond, S., Schuster, C., Patel, H., Xu, W., Carrascosa Carrillo, J.M.

Get full text

Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis by Latorre, I, Carrascosa, J.M, Vilavella, M, Díaz, J, Prat, C, Domínguez, J, Ferrándiz, C

“…Summary Objective In this study, we have performed a direct comparison between both T-cell based assays (QFN-G-IT and T-SPOT.TB) and TST in patients with…”
Get full text

Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort by Ruiz‐Genao, D., Perez‐Zafrilla, B., Lopez‐Estebaranz, J.L., Belinchón‐Romero, I., Carrascosa, J.M., Ferrán, M., Vanaclocha, F., Herrera‐Ceballos, E., García‐Doval, I.

Get full text

The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis by Egeberg, A., Gisondi, P., Carrascosa, J.M., Warren, R.B., Mrowietz, U.

“…Alterations in the innate and adaptive immunity underpin psoriasis pathophysiology, with the Th17 cells subset now recognized as the fundamental cells in the…”
Get full text

Innovation in Atopic Dermatitis: From Pathogenesis to Treatment by Munera-Campos, M, Carrascosa, J M

Get full text

Decreased leptin uptake in hypothalamic nuclei with ageing in Wistar rats by Fernandez-Galaz, C, Fernandez-Agullo, T, Campoy, F, Arribas, C, Gallardo, N, Andres, A, Ros, M, Carrascosa, JM

“…Leptin interacts with specific receptors in hypothalamic nuclei and modulates energy balance. Growing evidence has shown the association of obesity and…”
Get full text

Position statement for the management of comorbidities in psoriasis by Dauden, E., Blasco, A.J., Bonanad, C., Botella, R., Carrascosa, J.M., González‐Parra, E., Jodar, E., Joven, B., Lázaro, P., Olveira, A., Quintero, J., Rivera, R.

“…Background The association between psoriasis and some diseases has become relevant in recent years. Providing appropriate management of psoriasis from an early…”
Get full text

Prevalence of psoriasis in Spain in the age of biologics by Ferrándiz, C, Carrascosa, J M, Toro, M

“…INTRODUCTIONThe prevalence of psoriasis in Spain was estimated to be 1.4% before the advent of biologic agents. Fifteen years later, new therapeutic options…”
Get full text

Differential gene expression of insulin receptor isoforms A and B and insulin receptor substrates 1, 2 and 3 in rat tissues: modulation by aging and differentiation in rat adipose tissue by Serrano, R, Villar, M, Martínez, C, Carrascosa, J M, Gallardo, N, Andrés, A

“…The insulin receptor (IR) occurs as two alternatively spliced isoforms, IR-A (exon 11−) and IR-B (exon 11+), which exhibit functional differences and are…”
Get full text

Narrow-band ultraviolet B in aquagenic pruritus by Xifra, A., Carrascosa, J.M., Ferrándiz, C.

Get full text

Initial results of ixekizumab efficacy and safety in real‐world plaque psoriasis patients: a multicentre retrospective study by Deza, G., Notario, J., Lopez‐Ferrer, A., Vilarrasa, E., Ferran, M., del Alcazar, E., Carrascosa, J.M., Corral, M., Salleras, M., Ribera, M., Puig, L., Pujol, R. M., Vidal, D., Gallardo, F.

“…Background Ixekizumab (anti‐IL17A) is effective as treatment for moderate‐to‐severe plaque psoriasis, but real‐life data on effectiveness and safety are…”
Get full text